1. Introduction

1.1 The Insight Partners Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 North America Lung Cancer Therapy Market, by Country

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. North America Lung Cancer Therapy Market - Key Industry Dynamics

4.1 Market Drivers:

4.1.1 Increase in Cases of Lung Cancer

4.1.2 Government Initiatives for Screening and Treatment of Lung Cancer

4.2 Market Restraints

4.2.1 High Cost of Lung Cancer Therapy

4.3 Market Opportunities

4.3.1 Rising Number of Lung Cancer Therapy in Clinical Trials

4.4 Future Trends

4.4.1 Growing Demand for Targeted Therapy

4.5 Impact Analysis:

5. Lung Cancer Therapy Market - North America Market Analysis

5.1 North America Lung Cancer Therapy Market Revenue (US$ Mn), 2020 - 2030

6. North America Lung Cancer Therapy Market - Revenue and Forecast to 2030 - by Therapy Type

6.1 Overview

6.2 North America Lung Cancer Therapy Market Revenue Share, by Therapy Type, 2022 & 2030 (%)

6.3 Non-Invasive Therapy

6.3.1 Overview

6.3.2 Non-Invasive Therapy: North America Lung Cancer Therapy Market - Revenue and Forecast to 2030 (US$ Million)

6.4 Minimally Invasive

6.4.1 Overview

6.4.2 Minimally Invasive: North America Lung Cancer Therapy Market - Revenue and Forecast to 2030 (US$ Million)

6.4.3 North America Lung Cancer Therapy Market, by Minimally Invasive, 2020-2030 (US$ Million)

7. North America Lung Cancer Therapy Market - Revenue and Forecast to 2030 - by Indication

7.1 Overview

7.2 North America Lung Cancer Therapy Market Revenue Share, by Indication, 2022 & 2030 (%)

7.3 Non-Small Cell Lung Cancer

7.3.1 Overview

7.3.2 Non-Small Cell Lung Cancer: North America Lung Cancer Therapy Market - Revenue and Forecast to 2030 (US$ Million)

7.4 Small Cell Lung Cancer

7.4.1 Overview

7.4.2 Small Cell Lung Cancer: North America Lung Cancer Therapy Market - Revenue and Forecast to 2030 (US$ Million)

8. North America Lung Cancer Therapy Market - Revenue and Forecast to 2030 - by End User

8.1 Overview

8.2 North America Lung Cancer Therapy Market Revenue Share, by End User, 2022 & 2030 (%)

8.3 Hospitals

8.3.1 Overview

8.3.2 Hospitals: North America Lung Cancer Therapy Market - Revenue and Forecast to 2030 (US$ Million)

8.4 Oncology Clinics

8.4.1 Overview

8.4.2 Oncology Clinics: North America Lung Cancer Therapy Market - Revenue and Forecast to 2030 (US$ Million)

8.5 Research Centers

8.5.1 Overview

8.5.2 Research Centers: North America Lung Cancer Therapy Market - Revenue and Forecast to 2030 (US$ Million)

8.6 Others

8.6.1 Overview

8.6.2 Others: North America Lung Cancer Therapy Market - Revenue and Forecast to 2030 (US$ Million)

9. North America Lung Cancer Therapy Market - Country Analysis

9.1.1 North America North America Lung Cancer Therapy Market, by Country

9.1.1.1 US

9.1.1.1.1 Overview

9.1.1.1.2 US: North America Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)

9.1.1.1.3 US: North America Lung Cancer Therapy Market, by Therapy Type, 2020-2030 (US$ Million)

9.1.1.1.3.1 US: North America Lung Cancer Therapy Market, by Minimally Invasive, 2020-2030 (US$ Million)

9.1.1.1.4 US: North America Lung Cancer Therapy Market, by Indication, 2020-2030 (US$ Million)

9.1.1.1.5 US: North America Lung Cancer Therapy Market, by End User, 2020-2030 (US$ Million)

9.1.1.2 Canada

9.1.1.2.1 Overview

9.1.1.2.2 Canada: North America Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)

9.1.1.2.3 Canada: North America Lung Cancer Therapy Market, by Therapy Type, 2020-2030 (US$ Million)

9.1.1.2.3.1 Canada: North America Lung Cancer Therapy Market, by Minimally Invasive, 2020-2030 (US$ Million)

9.1.1.2.4 Canada: North America Lung Cancer Therapy Market, by Indication, 2020-2030 (US$ Million)

9.1.1.2.5 Canada: North America Lung Cancer Therapy Market, by End User, 2020-2030 (US$ Million)

9.1.1.3 Mexico

9.1.1.3.1 Overview

9.1.1.3.2 Mexico: North America Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)

9.1.1.3.3 Mexico: North America Lung Cancer Therapy Market, by Therapy Type, 2020-2030 (US$ Million)

9.1.1.3.3.1 Mexico: North America Lung Cancer Therapy Market, by Minimally Invasive, 2020-2030 (US$ Million)

9.1.1.3.4 Mexico: North America Lung Cancer Therapy Market, by Indication, 2020-2030 (US$ Million)

9.1.1.3.5 Mexico: North America Lung Cancer Therapy Market, by End User, 2020-2030 (US$ Million)

10. Lung Cancer Therapy Market - Industry Landscape

10.1 Overview

10.2 Growth Strategies in North America Lung Cancer Therapy Market

10.3 Inorganic Growth Strategies

10.3.1 Overview

10.4 Organic Growth Strategies

10.4.1 Overview

11. Company Profiles

11.1 Medtronic Plc

11.1.1 Key Facts

11.1.2 Business Description

11.1.3 Products and Services

11.1.4 Financial Overview

11.1.5 SWOT Analysis

11.1.6 Key Developments

11.2 RF Medical Co Ltd

11.2.1 Key Facts

11.2.2 Business Description

11.2.3 Products and Services

11.2.4 Financial Overview

11.2.5 SWOT Analysis

11.2.6 Key Developments

11.3 Johnson & Johnson

11.3.1 Key Facts

11.3.2 Business Description

11.3.3 Products and Services

11.3.4 Financial Overview

11.3.5 SWOT Analysis

11.3.6 Key Developments

11.4 Merck KGaA

11.4.1 Key Facts

11.4.2 Business Description

11.4.3 Products and Services

11.4.4 Financial Overview

11.4.5 SWOT Analysis

11.4.6 Key Developments

11.5 Sun Pharmaceutical Industries Ltd

11.5.1 Key Facts

11.5.2 Business Description

11.5.3 Products and Services

11.5.4 Financial Overview

11.5.5 SWOT Analysis

11.5.6 Key Developments

11.6 Bioventus Inc

11.6.1 Key Facts

11.6.2 Business Description

11.6.3 Products and Services

11.6.4 Financial Overview

11.6.5 SWOT Analysis

11.6.6 Key Developments

11.7 Olympus Corp

11.7.1 Key Facts

11.7.2 Business Description

11.7.3 Products and Services

11.7.4 Financial Overview

11.7.5 SWOT Analysis

11.7.6 Key Developments

11.8 Meiji Seika Pharma Co Ltd

11.8.1 Key Facts

11.8.2 Business Description

11.8.3 Products and Services

11.8.4 Financial Overview

11.8.5 SWOT Analysis

11.8.6 Key Developments

11.9 Advanz Pharma Corp

11.9.1 Key Facts

11.9.2 Business Description

11.9.3 Products and Services

11.9.4 Financial Overview

11.9.5 SWOT Analysis

11.9.6 Key Developments

12. Appendix

12.1 About Us

12.2 Glossary of Terms

List of Tables

Table 1. North America Lung Cancer Therapy Market Segmentation

Table 2. North America Lung Cancer Therapy Market, by Minimally Invasive- Revenue and Forecast to 2030 (US$ Million)

Table 3. US North America Lung Cancer Therapy Market, by Therapy Type - Revenue and Forecast to 2030 (US$ Million)

Table 4. US: North America Lung Cancer Therapy Market, by Minimally Invasive- Revenue and Forecast to 2030 (US$ Million)

Table 5. US: North America Lung Cancer Therapy Market, by Indication- Revenue and Forecast to 2030 (US$ Million)

Table 6. US: North America Lung Cancer Therapy Market, by End User- Revenue and Forecast to 2030 (US$ Million)

Table 7. Canada: North America Lung Cancer Therapy Market, by Therapy Type - Revenue and Forecast to 2030 (US$ Million)

Table 8. Canada: North America Lung Cancer Therapy Market, by Minimally Invasive- Revenue and Forecast to 2030 (US$ Million)

Table 9. Canada: North America Lung Cancer Therapy Market, by Indication- Revenue and Forecast to 2030 (US$ Million)

Table 10. Canada: North America Lung Cancer Therapy Market, by End User- Revenue and Forecast to 2030 (US$ Million)

Table 11. Mexico: North America Lung Cancer Therapy Market, by Therapy Type - Revenue and Forecast to 2030 (US$ Million)

Table 12. Mexico: North America Lung Cancer Therapy Market, by Minimally Invasive- Revenue and Forecast to 2030 (US$ Million)

Table 13. Mexico: North America Lung Cancer Therapy Market, by Indication- Revenue and Forecast to 2030 (US$ Million)

Table 14. Mexico: North America Lung Cancer Therapy Market, by End User- Revenue and Forecast to 2030 (US$ Million)

Table 15. Recent Inorganic Growth Strategies in the North America Lung Cancer Therapy Market

Table 16. Recent Organic Growth Strategies in North America Lung Cancer Therapy Market

Table 17. Glossary of Terms, North America Lung Cancer Therapy Market

List of Figures

Figure 1. North America Lung Cancer Therapy Market Segmentation, By Country

Figure 2. North America Lung Cancer Therapy Market - Key Industry Dynamics

Figure 3. Impact Analysis of Drivers and Restraints

Figure 4. North America Lung Cancer Therapy Market Revenue (US$ Mn), 2020 - 2030

Figure 5. North America Lung Cancer Therapy Market Revenue Share, by Therapy Type, 2022 & 2030 (%)

Figure 6. Non-Invasive Therapy: North America Lung Cancer Therapy Market - Revenue and Forecast to 2030 (US$ Million)

Figure 7. Minimally Invasive: North America Lung Cancer Therapy Market - Revenue and Forecast to 2030 (US$ Million)

Figure 8. North America Lung Cancer Therapy Market Revenue Share, by Indication, 2022 & 2030 (%)

Figure 9. Non-Small Cell Lung Cancer: North America Lung Cancer Therapy Market - Revenue and Forecast to 2030 (US$ Million)

Figure 10. Small Cell Lung Cancer: North America Lung Cancer Therapy Market - Revenue and Forecast to 2030 (US$ Million)

Figure 11. North America Lung Cancer Therapy Market Revenue Share, End User, 2022 & 2030 (%)

Figure 12. Hospitals: North America Lung Cancer Therapy Market - Revenue and Forecast to 2030 (US$ Million)

Figure 13. Oncology Clinics: North America Lung Cancer Therapy Market - Revenue and Forecast to 2030 (US$ Million)

Figure 14. Research Centers: North America Lung Cancer Therapy Market - Revenue and Forecast to 2030 (US$ Million)

Figure 15. Others: North America Lung Cancer Therapy Market - Revenue and Forecast to 2030 (US$ Million)

Figure 16. North America: North America Lung Cancer Therapy Market, by Key Country - Revenue (2022) (US$ Million)

Figure 17. North America North America Lung Cancer Therapy Market, By Key Countries, 2022 and 2030 (%)

Figure 18. US: North America Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)

Figure 19. Canada: North America Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)

Figure 20. Mexico: North America Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)

Figure 21. Growth Strategies in North America Lung Cancer Therapy Market